Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 21 Mar 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical publishes Annual Report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 14 Mar 2024 08:17 CET |
THOR MEDICAL ASA | Thor Medical ASA receives Innovation Norway grant for lab and pilot facilities at Herøya | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Mar 2024 07:30 CET |
THOR MEDICAL ASA | THOR MEDICAL ASA EMPLOYS BREDE ELLINGSÆTER AS CFO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 28 Feb 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA reports 2023 results - current focus on establishing pilot plant | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 21 Feb 2024 08:03 CET |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's second half results 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Feb 2024 07:30 CET |
THOR MEDICAL ASA | THOR MEDICAL EMPLOYS JASPER KURTH AS NEW CEO | 20103010 Biotechnology | Inside information |
| 19 Jan 2024 16:27 CET |
THOR MEDICAL ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Dec 2023 12:40 CET |
THOR MEDICAL ASA | Thor Medical ASA builds lab and pilot facilities at Herøya as key milestones towards industrial-scale production of alpha emitters | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Nov 2023 20:06 CET |
THOR MEDICAL ASA | Thor Medical signs agreement to transfer its Nordic Nanovector patents to NucliThera | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Nov 2023 08:30 CET |
THOR MEDICAL ASA | Thor Medical ASA signs LOI for offtake with US and Scandinavian based clinical trial stage companies | 20103010 Biotechnology | Non-regulatory press releases |
| 31 Oct 2023 16:45 CET |
THOR MEDICAL ASA | Thor Medical ASA expands expertise and positions for growth with two experienced chemistry professionals | 20103010 Biotechnology | Non-regulatory press releases |
| 31 Aug 2023 07:00 CEST |
THOR MEDICAL ASA | Thor Medical ASA first half 2023 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 17 Aug 2023 15:39 CEST |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's first half results 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Jul 2023 10:45 CEST |
NORDIC NANOVECTOR | Thor Medical – New share capital and name registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jul 2023 07:54 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 03 Jul 2023 21:34 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Notification of transactions by close associates of primary insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Jul 2023 18:08 CEST |
NORDIC NANOVECTOR | The acquisition of Thor Medical AS is completed | 20103010 Biotechnology | Inside information |
| 03 Jul 2023 16:11 CEST |
NORDIC NANOVECTOR | Nordic Nanovector – Issuance of shares to former board members and restricted stock units (RSU) to current board members | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Jun 2023 11:47 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 29 Jun 2023 11:46 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 29 Jun 2023 11:45 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 28 Jun 2023 16:45 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - Appointment of Alf Bjørseth as CEO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Jun 2023 16:30 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - Completion of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jun 2023 14:26 CEST |
NORDIC NANOVECTOR | NANOV AGM - Disclosure of proxies | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jun 2023 14:10 CEST |
NORDIC NANOVECTOR | NANOV AGM - Publication of Exempted Document | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jun 2023 16:27 CEST |
NORDIC NANOVECTOR | NANOV - Endring i forslag til vedtak 14 på GF 28.juni 2023 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 22 Jun 2023 14:36 CEST |
NORDIC NANOVECTOR | Jostein Dahle, Chief Scientific Officer and Co-Founder, leaves the Company | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 14:36 CEST |
NORDIC NANOVECTOR | Jostein Dahle forlater Nordic Nanovector | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 15 Jun 2023 13:13 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - GF vedlegg | 20103010 Biotechnology | Årsrapporter og revisjonsberetninger |
| 15 Jun 2023 13:13 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - AGM attachments | 20103010 Biotechnology | Annual financial and audit Reports |
| 07 Jun 2023 14:46 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - Mandatory notification of trade - primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Jun 2023 14:30 CEST |
NORDIC NANOVECTOR | Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Jun 2023 13:44 CEST |
NORDIC NANOVECTOR | Styreleder kjøper aksjer i Nordic Nanovector | 20103010 Biotechnology | Meldepliktig handel for primærinnsidere |
| 07 Jun 2023 13:44 CEST |
NORDIC NANOVECTOR | The Chairman of the Board buys shares in Nordic Nanovector | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Jun 2023 20:37 CEST |
NORDIC NANOVECTOR | NANOV announces agreement to acquire Thor Medical | 20103010 Biotechnology | Innsideinformasjon |
| 06 Jun 2023 20:10 CEST |
NORDIC NANOVECTOR | Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer | 20103010 Biotechnology | Inside information |
| 18 Apr 2023 11:15 CEST |
NORDIC NANOVECTOR | Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database | 20103010 Biotechnology | Non-regulatory press releases |
| 31 Mar 2023 08:45 CEST |
NORDIC NANOVECTOR | NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED | 20103010 Biotechnology | Non-regulatory press releases |
| 23 Mar 2023 11:00 CET |
NORDIC NANOVECTOR | NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED | 20103010 Biotechnology | Annual financial and audit Reports |